PharmaShots Weekly Snapshots (November 15 - 19, 2021)
Published: Nov 19, 2021 | Tags: Jazz, Sunosi, solriamfetol, NICE, Recommendation, Excessive Daytime Sleepiness, Narcolepsy
Published: Nov 19, 2021 | Tags: Antengene, Selinexor, ATG-010, NMPA, IND, Approval, P-I/II, SWATCH Study, Selinexor, ATG-010, Non-Hodgkin Lymphoma
Published: Nov 19, 2021 | Tags: Daiichi Sankyo, Quizartinib, P-III, QuANTUM-First Trial, FLT3-ITD Positive AML
Gilead Exercises its Options with Arcus for its Three Clinical-Stage Programs to Treat Cancers
Published: Nov 19, 2021 | Tags: Gilead, Exercises, Options, Arcus, domvanalimab, AB308, etrumadenant, quemliclustat, Cancers
Published: Nov 19, 2021 | Tags: Merck, Keytruda, pembrolizumab, US, FDA, Approval, Renal Cell Carcinoma
Novo Nordisk to Acquire Dicerna for ~$3.3B
Published: Nov 19, 2021 | Tags: Novo Nordisk, Acquire, Dicerna, ~$3.3B
Published: Nov 18, 2021 | Tags: GSK, Nucala, mepolizumab, EC, Approval, Eosinophil-Driven Diseases
Published: Nov 18, 2021 | Tags: AstraZeneca, AZD7442, P-III, PROVENT, TACKLE Trial, COVID-19
Published: Nov 18, 2021 | Tags: OncoOne, GenScript ProBio, Monoclonal Antibody, oxMIF
Published: Nov 18, 2021 | Tags: AstraZeneca, Lokelma, Fast Track Designation, Chronic Haemodialysis, Hyperkalaemia
Merck KGaA Collaborated with Burning Rock for Liquid-biopsy Based CDx Development
Published: Nov 18, 2021 | Tags: Merck KGaA, Burning Rock, Liquid-biopsy, CDx Development
Published: Nov 18, 2021 | Tags: Takeda, Denali, DNL593, PTV:PGRN, Frontotemporal Dementia-Granulin
Published: Nov 17, 2021 | Tags: Merck, Ridgeback, Molnupiravir, P-III, MOVe-OUT Trial, COVID-19, ASTMH 2021
Published: Nov 17, 2021 | Tags: AbbVie, Skyrizi, Risankizumab, EC, Approval, Active Psoriatic Arthritis
Published: Nov 17, 2021 | Tags: Biogen, Vumerity, diroximel fumarate, EC, Approval, Multiple Sclerosis
Merck Reports Results of Arpraziquante in P-III Clinical Trial for the Treatment of Schistosomiasis
Published: Nov 17, 2021 | Tags: Merck, Arpraziquante, P-III, Clinical Trial, Schistosomiasis
Published: Nov 17, 2021 | Tags: Viatris, Biocon, Semglee, Insulin Glargine, insulin glargine-yfgn, Diabetes
Published: Nov 17, 2021 | Tags: Sotio, LegoChem Biosciences, Novel Therapeutics, Solid Tumors
Mirum Reports Six Years Results of LIvmarli (maralixibat) for the Treatment of Alagille Syndrome
Published: Nov 16, 2021 | Tags: Mirum, LIvmarli, maralixibat, Alagille Syndrome
Celltrion’s Regdanvimab Receives the EC’s Approval for the Treatment of COVID-19
Published: Nov 16, 2021 | Tags: Celltrion, Regdanvimab, EC, Approval, COVID-19
Published: Nov 16, 2021 | Tags: AstraZeneca, Moderna, AZD8601, P-IIa, EPICCURE Trial, Heart Failure, AHA 2021
Entos Entered into an Agreement with BioMarin for Gene Therapies to Treat Genetic Diseases
Published: Nov 16, 2021 | Tags: Entos, BioMarin, Gene Therapies, Genetic Diseases
Published: Nov 16, 2021 | Tags: Janssen, BMS, Milvexian, P-II, AXIOMATIC-TKR Study, TKR Surgery, AHA 2021, NEJM
Published: Nov 16, 2021 | Tags: Coherus, Junshi, Toripalimab, US, FDA, Orphan Drug Designation, Esophageal Cancer
AcelRx to Acquire Lowell for ~$32.5M
Published: Nov 15, 2021 | Tags: AcelRx, Acquire, Lowell, ~$32.5M
Published: Nov 15, 2021 | Tags: Vertex, Kaftrio, ivacaftor, tezacaftor, elexacaftor, Ivacaftor, CHMP, Cystic Fibrosis
Published: Nov 15, 2021 | Tags: Innovent, IBI302, P-Ib, Clinical Trial, Neovascular Age-Related Macular Degeneration, AAO 2021
Published: Nov 15, 2021 | Tags: Regenxbio, RGX-314, P-II, AAVIATE, ALTITUDE Trials, Wet AMD, Diabetic Retinopathy, AAO 2021
Published: Nov 15, 2021 | Tags: GSK, Vir, Sotrovimab, P-III, COMET-TAIL Trial, COVID-19
Published: Nov 15, 2021 | Tags: Amgen, Lumykras, sotorasib, CHMP, KRAS G12C-Mutated, Non-Small Cell Lung Cancer
Related Post: PharmaShots Weekly Snapshots (November 08 - 12, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com